Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial

Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the RGX-121 gene therapy study in children with MPS II, including participation details, study design, and measured outcomes.
    Difference
    58%
    Check dated 2026-11-11T00:55:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:21:26.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition and links to updates and FAQs. The footer revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:52:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, while the study page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:09:44.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a minimal header and a Home link. This indicates access to the study record is blocked rather than updated with new study information.
    Difference
    20%
    Check dated 2026-09-23T00:00:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision metadata on the study page was updated from v3.6.6 to v3.7.0. This indicates a software update to the page rendering or underlying platform rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T22:55:40.000Z thumbnail image

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.